 Mitochondrial DNA Parkinson disease major lines evidence support hypothesis impairment mitochondrial function neuronal death Parkinson disease First neurotoxicity parkinsonism-inducing compound MPTP due generation MPP+ metabolite central nervous system toxicity MPP+ likely ability mitochondrial electron flow level complex Second recent studies deficiency mitochondrial complex activity brain tissues parkinsonian patients enzyme activity reduction defect genes subunits complex genes mitochondrial genome conceivable abnormal mitochondrial DNA mtDNA role pathogenesis Parkinson disease entire sequence human mitochondrial genome human mtDNA techniques polymerase chain reaction Therefore identification detectable mtDNA alteration marker diagnosis screening Parkinson disease